| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 623527 | Pyrrolidinium, N-(5-carboxypentyl)-N- [2-[2-[3-(octadecyloxy)-2-[(pyrimidine-2yl)oxy]propyloxy] ethoxy]ethyl]-, inner salt | 0.00289834947687851 | 0.22048937 |
| NSC 650263 | Null | 0.00289834947687851 | 0.010536814 |
| NSC 685014 | Null | 0.00289834947687851 | 0.32677231 |
| NSC 718728 | 5-[2-(2,5-Dimethoxyphenyl)ethynyl]-2-methoxyphenyl-N- [2-(4-fluorophenyl)ethyl]carboxamide | 0.00289834947687851 | 0.60203966 |
| NSC 620327 | Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester | 0.00334162892839391 | -0.24224767 |
| NSC 639520 | Cyclohexanone, 2-[(2-methoxyphenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride | 0.00334162892839391 | 0.28944852 |
| NSC 114346 | Null | 0.00337662564965909 | 0.700653 |
| NSC 173552 | L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate | 0.00337662564965909 | 0.44914787 |
| NSC 269720 | Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- | 0.00337662564965909 | 0.27251093 |
| NSC 638409 | (E)N-Ethyl-[3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl) prop-2-enoamide | 0.00337662564965909 | 0.6352346 |